Literature DB >> 21596766

Tight squeeze, slow burn: inflammation and the aetiology of cervical myelopathy.

Michael S Beattie1, Geoffrey T Manley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21596766      PMCID： PMC3139947          DOI： 10.1093/brain/awr088

Source DB:  PubMed          Journal:  Brain        ISSN： 0006-8950            Impact factor:   13.501


× No keyword cloud information.
  16 in total

1.  ProNGF induces p75-mediated death of oligodendrocytes following spinal cord injury.

Authors:  Michael S Beattie; Anthony W Harrington; Ramee Lee; Ju Young Kim; Sheri L Boyce; Frank M Longo; Jacqueline C Bresnahan; Barbara L Hempstead; Sung Ok Yoon
Journal:  Neuron       Date:  2002-10-24       Impact factor: 17.173

2.  Inhibition of Fas-mediated apoptosis through administration of soluble Fas receptor improves functional outcome and reduces posttraumatic axonal degeneration after acute spinal cord injury.

Authors:  Alun Ackery; Sherri Robins; Michael G Fehlings
Journal:  J Neurotrauma       Date:  2006-05       Impact factor: 5.269

3.  Human neuropathological and animal model evidence supporting a role for Fas-mediated apoptosis and inflammation in cervical spondylotic myelopathy.

Authors:  Wen Ru Yu; Tianyi Liu; Tim-Rasmus Kiehl; Michael G Fehlings
Journal:  Brain       Date:  2011-04-13       Impact factor: 13.501

4.  Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys.

Authors:  M J Crowe; J C Bresnahan; S L Shuman; J N Masters; M S Beattie
Journal:  Nat Med       Date:  1997-01       Impact factor: 53.440

Review 5.  Inflammation and apoptosis: linked therapeutic targets in spinal cord injury.

Authors:  Michael S Beattie
Journal:  Trends Mol Med       Date:  2004-12       Impact factor: 11.951

6.  The cellular inflammatory response in human spinal cords after injury.

Authors:  Jennifer C Fleming; Michael D Norenberg; David A Ramsay; Gregory A Dekaban; Alexander E Marcillo; Alvaro D Saenz; Melissa Pasquale-Styles; W Dalton Dietrich; Lynne C Weaver
Journal:  Brain       Date:  2006-10-28       Impact factor: 13.501

7.  Neutralization of CD95 ligand promotes regeneration and functional recovery after spinal cord injury.

Authors:  Deana Demjen; Stefan Klussmann; Susanne Kleber; Cecilia Zuliani; Bram Stieltjes; Corinna Metzger; Ulrich A Hirt; Henning Walczak; Werner Falk; Marco Essig; Lutz Edler; Peter H Krammer; Ana Martin-Villalba
Journal:  Nat Med       Date:  2004-03-07       Impact factor: 53.440

Review 8.  A review of the pathophysiology of cervical spondylotic myelopathy with insights for potential novel mechanisms drawn from traumatic spinal cord injury.

Authors:  M G Fehlings; G Skaf
Journal:  Spine (Phila Pa 1976)       Date:  1998-12-15       Impact factor: 3.468

9.  Minocycline treatment reduces delayed oligodendrocyte death, attenuates axonal dieback, and improves functional outcome after spinal cord injury.

Authors:  David P Stirling; Kourosh Khodarahmi; Jie Liu; Lowell T McPhail; Christopher B McBride; John D Steeves; Matt S Ramer; Wolfram Tetzlaff
Journal:  J Neurosci       Date:  2004-03-03       Impact factor: 6.167

10.  Inflammation stimulates myelination by transplanted oligodendrocyte precursor cells.

Authors:  Anna Setzu; Justin D Lathia; Chao Zhao; Karen Wells; Mahendra S Rao; Charles Ffrench-Constant; Robin J M Franklin
Journal:  Glia       Date:  2006-09       Impact factor: 7.452
View more
  12 in total

1.  Role of MK2 signaling pathway in the chronic compression of cervical spinal cord.

Authors:  Hongxing Song; Xiutong Fang; Mingjie Wen; Fang Yu; Kai Gao; Chenli Sun; Zhenwei Wang
Journal:  Am J Transl Res       Date:  2015-11-15       Impact factor: 4.060

2.  Magnetic Resonance Imaging Biomarker of Axon Loss Reflects Cervical Spondylotic Myelopathy Severity.

Authors:  Rory K J Murphy; Peng Sun; Junqian Xu; Yong Wang; Samir Sullivan; Paul Gamble; Joanne Wagner; Neill N Wright; Ian G Dorward; Daniel Riew; Paul Santiago; Michael P Kelly; Kathryn Trinkaus; Wilson Z Ray; Sheng-Kwei Song
Journal:  Spine (Phila Pa 1976)       Date:  2016-05       Impact factor: 3.468

Review 3.  Mechanical and cellular processes driving cervical myelopathy.

Authors:  Roisin T Dolan; Joseph S Butler; John M O'Byrne; Ashley R Poynton
Journal:  World J Orthop       Date:  2016-01-18

Review 4.  Degenerative cervical myelopathy - update and future directions.

Authors:  Jetan H Badhiwala; Christopher S Ahuja; Muhammad A Akbar; Christopher D Witiw; Farshad Nassiri; Julio C Furlan; Armin Curt; Jefferson R Wilson; Michael G Fehlings
Journal:  Nat Rev Neurol       Date:  2020-01-23       Impact factor: 42.937

5.  Treatment considerations of cervical spondylotic myelopathy.

Authors:  Ehab Shiban; Bernhard Meyer
Journal:  Neurol Clin Pract       Date:  2014-08

6.  The Restless Spinal Cord in Degenerative Cervical Myelopathy.

Authors:  M Hupp; N Pfender; K Vallotton; J Rosner; S Friedl; C M Zipser; R Sutter; M Klarhöfer; J M Spirig; M Betz; M Schubert; P Freund; M Farshad; A Curt
Journal:  AJNR Am J Neuroradiol       Date:  2021-02-04       Impact factor: 3.825

Review 7.  Degenerative Cervical Myelopathy: A Clinical Review.

Authors:  Justin Gibson; Aria Nouri; Bryan Krueger; Nikita Lakomkin; Rani Nasser; David Gimbel; Joseph Cheng
Journal:  Yale J Biol Med       Date:  2018-03-28

8.  Clinical outcomes of epidural and intradural decompression for treatment of degenerative cervical myelopathy.

Authors:  Genlong Jiao; Zhizhong Li; Pan Zhou; Jinpei Yang; Xueshi Li
Journal:  J Int Med Res       Date:  2020-06       Impact factor: 1.671

9.  The incidence of cervical spondylosis decreases with aging in the elderly, and increases with aging in the young and adult population: a hospital-based clinical analysis.

Authors:  Chuanling Wang; Fuming Tian; Yingjun Zhou; Wenbo He; Zhiyou Cai
Journal:  Clin Interv Aging       Date:  2016-01-12       Impact factor: 4.458

10.  Association between Cervical Spondylosis and Migraine: A Nationwide Retrospective Cohort Study.

Authors:  Wang-Sheng Lin; Tung-Fu Huang; Tien-Yow Chuang; Cheng-Li Lin; Chia-Hung Kao
Journal:  Int J Environ Res Public Health       Date:  2018-03-25       Impact factor: 3.390
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.